tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Sanofi (SNYNF)
OTHER OTC:SNYNF
US Market
SNYNF
Sanofi
RESEARCH TOOLSreports
Advertisement

Sanofi (SNYNF) Stock News & Sentiment

Compare
380 Followers
Sanofi’s New Study on SAR446597: A Potential Game-Changer for Age-related Macular Degeneration
Premium
Company Announcements
Sanofi’s New Study on SAR446597: A Potential Game-Changer for Age-related Macular Degeneration
1d ago
SNYNF
Sanofi’s Promising Phase 3 Study on Duvakitug for Crohn’s Disease
Premium
Company Announcements
Sanofi’s Promising Phase 3 Study on Duvakitug for Crohn’s Disease
9d ago
SNYNF
Sanofi’s Phase 3 Study on Duvakitug: A Potential Game-Changer for Ulcerative Colitis
Premium
Company Announcements
Sanofi’s Phase 3 Study on Duvakitug: A Potential Game-Changer for Ulcerative Colitis
9d ago
SNYNF
Sanofi’s Promising Phase 3 Study on Duvakitug for Ulcerative Colitis
Premium
Company Announcements
Sanofi’s Promising Phase 3 Study on Duvakitug for Ulcerative Colitis
9d ago
SNYNF
Sanofi’s Phase 3 Study on Duvakitug: A Potential Game-Changer for Crohn’s Disease Treatment
Premium
Company Announcements
Sanofi’s Phase 3 Study on Duvakitug: A Potential Game-Changer for Crohn’s Disease Treatment
9d ago
SNYNF
Sanofi’s New Study on Beyfortus: A Closer Look at Market Implications
Premium
Company Announcements
Sanofi’s New Study on Beyfortus: A Closer Look at Market Implications
10d ago
SNYNF
Sanofi’s Pediatric Study on Unexplained Splenomegaly: Key Insights for Investors
Premium
Company Announcements
Sanofi’s Pediatric Study on Unexplained Splenomegaly: Key Insights for Investors
18d ago
SNYNF
More SNYNF News >

SNYNF News on the Web

Does Positive AlphaMedix Phase II Data Reinforce the Bull Case for Sanofi (ENXTPA:SAN)?
Simply Wall St
Neutral
Does Sanofi’s Recent 9.6% Rally Signal a Real Change in 2025 Valuation?
Simply Wall St
Neutral
Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Sanofi (SNYNF)
TipRanks News
Neutral
Sanofi (ENXTPA:SAN): Assessing Valuation as Shares Trade Below Analyst Targets
Simply Wall St
Neutral
UBS Reaffirms Their Buy Rating on Sanofi (SNYNF)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO) and Sanofi (OtherSNYNF)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Ligand Pharma (LGND)
TipRanks News
Neutral
Sanofi (ENXTPA:SAN): A Fresh Look at Valuation After Recent Share Price Shifts
Simply Wall St
Neutral

News Score - Last 7 Days

Neutral
SNYNF
Sector Average
Media Buzz
This Week3 articles
Weekly Average4 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SNYNF’s Media Buzz Sentiment?
3 articles about SNYNF were published this week. In an average week, 4 articles are published.
    What is SNYNF’s weekly average amount of articles?
    In an average week, 4 articles about SNYNF are published.
      What is SNYNF’s News Sentiment?
      50% of articles about SNYNF were positive this week, compared to its sector average of 55%.
        Healthcare Stocks that are Trending in the News
        EXASExact Sciences
        ELANElanco Animal Health
        NTLAIntellia Therapeutics
        LHLabcorp Holdings
        PHGKoninklijke Philips
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing